Skip to Main Content

Elanco Animal Health Incorporated Common Stock

ELAN Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ELAN by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 10, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 10, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 25, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 28, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 09, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 09, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 18, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 18, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 17, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 15, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 15, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Jun 05, 2024
Ro Khanna House / D Exchange None Mar 05, 2024
Ro Khanna House / D Exchange None Mar 05, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Feb 22, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Jan 12, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Jan 09, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Aug 04, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 03, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 02, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jul 27, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jul 25, 2023
Ro Khanna House / D Sale $50,001 - $100,000 May 23, 2023
Ro Khanna House / D Sale $1,001 - $15,000 May 19, 2023
Ro Khanna House / D Sale $15,001 - $50,000 Apr 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 31, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 13, 2023
Ro Khanna House / D Purchase $15,001 - $50,000 Mar 10, 2023
Daniel S. Goldman House / D Sale $1,001 - $15,000 Mar 06, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 24, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 21, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 14, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 05, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 30, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 27, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 23, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 22, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 21, 2022
ELAN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ELAN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ELAN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by ELAN's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ELAN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ELAN Income Statement
ELAN Balance Sheet
ELAN Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Formulation for the use in the simultaneous treatment of coccidial infections and iron deficiencies Nov. 26, 2024
  • Patent Title: Method for the synthesis of cyclic depsipeptides Oct. 22, 2024
  • Patent Title: Immunostimulatory oligonucleotides Mar. 19, 2024
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ELAN News

Recent insights relating to ELAN

CNBC Recommendations

Recent picks made for ELAN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ELAN

ELAN Analyst Ratings

ELAN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ELAN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ELAN stock a Buy, Sell, or Hold?

  • What is the price target for $ELAN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ELAN Top Shareholders
Shareholder
Shares Held
ELAN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ELAN stock?

  • Who owns the most shares of $ELAN stock?

  • What funds own $ELAN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ELAN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ELAN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top